CSI Specialty Group has announced the appointment of CSI President and CEO Suzette DiMascio, CHE, CMCE, CPC, to the National Stakeholder Advisory Panel of the Pharmacy Quality Alliance (PQA).
“We are proud to be part of such a credible and committed national body, dedicated to improving healthcare quality and patient safety as they relate to the appropriate use of medications,” says DiMascio. “The knowledge gained by our participation with PQA will enhance CSI Specialty Group’s ability to help our clients develop the right quality initiatives for the patients they serve.”
Established in 2006, the PQA strives to improve the quality of medication use and management across America in all healthcare settings. Working in collaboration with an extensive network of over 200 member organizations, the PQA improves patient health through the development and implementation of medication performance measures and the recognition of pharmacy excellence.
DiMascio is an influential contributor and thought leader to the specialty pharmacy and manufacturer community, Corporate Member of the Academy of Managed Care Pharmacy (AMCP), Founding Member of National Association of Specialty Pharmacy (NASP) and an Active Member in the Women Business Leaders of US HealthCare Industry (WBL).
CSI’s Leadership Team has more than 200 years of combined experience representing expertise from organizations like Aetna Specialty, Bayer, CVS Caremark, Cleveland Clinic and Florida Hospital, among others.